Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neratinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neratinibmarket, defines the market attractiveness level of Neratinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neratinib industry, describes the types of Neratinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neratinib market and the development prospects and opportunities of Neratinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neratinib market in Chapter 13.
By Player:
Puma Biotechnology
Beacon Pharmaceuticals Limited
By Type:
40mg/180 Tablets
40mg/150 Tablets
40mg/90 Tablets
By End-User:
Early Breast Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neratinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neratinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neratinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neratinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neratinib Market Analysis and Outlook to 2022
-
7.1 Global Neratinib Consumption (2017-2022)
-
7.2 United States Neratinib Consumption (2017-2022)
-
7.3 Europe Neratinib Consumption (2017-2022)
-
7.4 China Neratinib Consumption (2017-2022)
-
7.5 Japan Neratinib Consumption (2017-2022)
-
7.6 India Neratinib Consumption (2017-2022)
-
7.7 South Korea Neratinib Consumption (2017-2022)
8 Region and Country-wise Neratinib Market Analysis and Outlook to 2028
-
8.1 Global Neratinib Consumption Forecast (2022-2028)
-
8.2 United States Neratinib Consumption Forecast (2022-2028)
-
8.3 Europe Neratinib Consumption Forecast (2022-2028)
-
8.4 China Neratinib Consumption Forecast (2022-2028)
-
8.5 Japan Neratinib Consumption Forecast (2022-2028)
-
8.6 India Neratinib Consumption Forecast (2022-2028)
-
8.7 South Korea Neratinib Consumption Forecast (2022-2028)
9 Global Neratinib Market Outlook by Types and Applications to 2022
-
9.1 Global Neratinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 40mg/180 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 40mg/150 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 40mg/90 Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Neratinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Early Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Other Consumption and Growth Rate (2017-2022)
10 Global Neratinib Market Outlook by Types and Applications to 2028
-
10.1 Global Neratinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 40mg/180 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 40mg/150 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 40mg/90 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neratinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Early Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Neratinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neratinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neratinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neratinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neratinib Market Competitive Analysis
-
14.1 Puma Biotechnology
-
14.1.1 Puma Biotechnology Company Details
-
14.1.2 Puma Biotechnology Neratinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Puma Biotechnology Neratinib Product and Service
-
14.2 Beacon Pharmaceuticals Limited
-
14.2.1 Beacon Pharmaceuticals Limited Company Details
-
14.2.2 Beacon Pharmaceuticals Limited Neratinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Beacon Pharmaceuticals Limited Neratinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neratinib
-
Figure Neratinib Picture
-
Table Global Neratinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neratinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neratinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neratinib Consumption by Country (2017-2022)
-
Figure United States Neratinib Consumption and Growth Rate (2017-2022)
-
Table Europe Neratinib Consumption and Growth Rate (2017-2022)
-
Figure China Neratinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Neratinib Consumption and Growth Rate (2017-2022)
-
Figure India Neratinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neratinib Consumption and Growth Rate (2017-2022)
-
Figure Global Neratinib Consumption Forecast by Country (2022-2028)
-
Figure United States Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neratinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg/180 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg/150 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg/90 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Early Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg/180 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg/150 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg/90 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Early Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neratinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neratinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Puma Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Puma Biotechnology Neratinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Puma Biotechnology Neratinib Product and Service
-
Table Beacon Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharmaceuticals Limited Neratinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharmaceuticals Limited Neratinib Product and Service
-
